|国家科技期刊平台
首页|期刊导航|The Journal of Biomedical Research|Drug resistance mechanisms in cancers:Execution of prosurvival strategies

Drug resistance mechanisms in cancers:Execution of prosurvival strategiesOA

中文摘要

One of the quintessential challenges in cancer treatment is drug resistance.Several mechanisms of drug resistance have been described to date,and new modes of drug resistance continue to be discovered.The phenomenon of cancer drug resistance is now widespread,with approximately 90% of cancer-related deaths associated with drug resistance.Despite significant advances in the drug discovery process,the emergence of innate and acquired mechanisms of drug resistance has impeded the progress in cancer therapy.Therefore,understanding the mechanisms of drug resistance and the various pathways involved is integral to treatment modalities.In the present review,I discuss the different mechanisms of drug resistance in cancer cells,including DNA damage repair,epithelial to mesenchymal transition,inhibition of cell death,alteration of drug targets,inactivation of drugs,deregulation of cellular energetics,immune evasion,tumor-promoting inflammation,genome instability,and other contributing epigenetic factors.Furthermore,I highlight available treatment options and conclude with future directions.

Pavan Kumar Dhanyamraju;

Fels Cancer Institute of Personalized Medicine,Lewis-Katz School of Medicine,Temple University,Philadelphia,PA 19140,USA

临床医学

cancerdrug resistancemechanismsmicroRNAstreatment strategies

《The Journal of Biomedical Research》 2024 (002)

P.95-121 / 27

10.7555/JBR.37.20230248

评论